KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma

OBJECTIVES: There is no molecular biomarker available in the clinical practice to assess the prognosis of advanced pancreatic carcinoma. This multicenter prospective study aimed to investigate the role of KRAS mutation subtypes within the primary tumor to determine the prognosis of advanced pancreat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Transl Gastroenterol
Main Authors: Bournet, Barbara, Muscari, Fabrice, Buscail, Camille, Assenat, Eric, Barthet, Marc, Hammel, Pascal, Selves, Janick, Guimbaud, Rosine, Cordelier, Pierre, Buscail, Louis
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2016
Assuntos:
Original Contributions
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4822095/
https://ncbi.nlm.nih.gov/pubmed/27010960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ctg.2016.18
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares